Area
Reporting and discussion about Science & Medicine, with links to the original sources.
OpenAI lets health organizations connect authorized patient records to ChatGPT, with summaries citing the chart. On a podcast, Emad Mostaque urged AI double-checks of every health decision within a year or two, a proposal, not practice.
PSI's AI found in a week a cheap Alpha Centauri route that eluded StarCloud's Philip Johnston for six months: slow down, fall toward the sun, thrust at perihelion. The sub-$15M probe would take roughly 77,500 years and miss by about 2,600 AU.
David Friedberg argued AI can screen a million protein ideas on computers to find ones that might reverse cell aging, without a full theory of the cell. The eye work he cited has reached a first safety trial in people, not restored sight.
GenBio's AIDO Cell simulates a human cell that remembers successive edits and drugs. For now it helps prioritize experiments in two cell lines; lab validation of its novel predictions is underway. A Moonshots panelist called it the end of medicine.
Merck and Moderna said personalized mRNA therapy intismeran autogene plus Keytruda beat Keytruda alone on melanoma recurrence-free and distant-metastasis-free survival in a 1,137-patient phase 3 interim analysis. No effect sizes were released.
Brian Greene argues AI could make Newton-scale discoveries, expecting it to excel at exploring options and linking fields while humans, for now, lead in inventing new frameworks. He sees collaboration reshaping physicists' role.